A new study published in Personal Relationships explores how perceptions of a romantic partner's drinking habits are related to relationship satisfaction and mental health among young adults.
Preliminary research has found that cannabigerol (CBG), a compound from cannabis, reduces anxiety and stress without causing intoxication. It may also improve memory, making it a promising option for anxiety relief without typical cannabis side effects.
A recent study found that adding EEG neurofeedback training to standard alcohol rehabilitation improved emotional competencies and life satisfaction in participants with alcohol use disorder, highlighting its potential as a complementary treatment to enhance rehabilitation outcomes.
Scientists have found that high doses of cannabidiol (CBD) do not reduce but instead enhance the psychoactive effects of tetrahydrocannabinol (THC), challenging the belief that CBD mitigates THC's adverse effects.
Researchers found that low-dose, long-term THC treatment in mice reverses brain aging by boosting cognitive function and synapse formation, while also showing anti-aging effects through dual-phase changes in mTOR signaling and metabolism.
Psychedelics impair attention and decision-making during use but may boost creativity afterward. In contrast, MDMA primarily disrupts memory, with no lasting cognitive benefits—highlighting the complex, varied effects of these substances on the brain.
A meta-analysis indicates that high-dose psilocybin slightly outperforms escitalopram for treating depression. However, the research also suggests previous estimates of psychedelics' efficacy have been overstated due to issues with blinding in trials.
LSD alters brain activity and connectivity in key regions associated with pain processing, offering potential insights for pain management and the therapeutic use of psychedelics.
Researchers found that DMT alters the primary visual cortex by expanding the population receptive fields of neurons. This helps explain the intense visual experiences reported by users.
A recent study found that 2% to 21% of cannabis users experience psychotic symptoms, with higher rates linked to THC. Experimental studies showed the highest rates, while medicinal cannabis studies reported the lowest.
A recent study found that prenatal exposure to cannabis components THC and CBD in rodents led to reduced birth size, behavioral changes, and disrupted brain activity, indicating potential long-term neurodevelopmental risks for offspring.
Children of parents with alcohol use disorders inherit mitochondrial dysfunction, leading to early aging symptoms such as high cholesterol, heart problems, arthritis, and early onset dementia.
New research explores how music could influence patient experiences during intranasal ketamine therapy for treatment-resistant depression, potentially opening doors to more effective and comfortable treatment protocols.
Psychedelics like psilocybin and 2C-B distort memory familiarity, increasing false recognitions of emotional stimuli, suggesting a shared neurocognitive mechanism that might underlie their unique effects on consciousness and cognition.
MDMA-assisted psychotherapy is linked to mild to moderate, transient side effects, such as anxiety and nausea. However, concerning gaps in current research highlight the need for further studies to better understand its safety profile.